This content was written and submitted by the supplier. It has only been modified to comply with this publication’s space and style.
The RIVA System will be used in RVH's new Chemo Centre; under construction as part of the hospital's $400 million redevelopment slated to open in September 2011.
“The strategic investment and introduction of the RIVA System into Canadian hospitals and pharmacies is a tremendous landmark in the adaptation of robotic innovation,” acknowledges Niels Erik Hansen, Chief Executive Officer of IH Systems. “RVH's commitment to innovative medical practices is a true testament to the organization and its staff,” he concludes.
In addition to supporting USP 797 compliance, a set of strict medical compliances not mandatory for Canadian hospitals but one RVH continually seeks to achieve, the RIVA System will allow the hospital to compound ready-to-use sterile doses that are currently manually compounded. For Ben Szuuts, Sales Manager for Manrex Limited, the organization responsible for the sale of the RIVA System, collaborating with RVH on this milestone project has reinforced the important role robotic automation plays in the evolution of healthcare. “The signing of this agreement with RVH is another step in the right direction for Canadian Healthcare,” says Szuuts. “We are very excited to be working with RVH. Their commitment to patient and staff safety solidifies their position as leaders in Canadian Healthcare.”
RIVA (Robotic IV Automation System) -a self-contained unit for filling IV syringes and bags- is the first product developed by Winnipeg-based medical device company Intelligent Hospital Systems. To view our latest video of RIVA in operation, click here
“The strategic investment and introduction of the RIVA System into Canadian hospitals and pharmacies is a tremendous landmark in the adaptation of robotic innovation,” acknowledges Niels Erik Hansen, Chief Executive Officer of IH Systems. “RVH's commitment to innovative medical practices is a true testament to the organization and its staff,” he concludes.
In addition to supporting USP 797 compliance, a set of strict medical compliances not mandatory for Canadian hospitals but one RVH continually seeks to achieve, the RIVA System will allow the hospital to compound ready-to-use sterile doses that are currently manually compounded. For Ben Szuuts, Sales Manager for Manrex Limited, the organization responsible for the sale of the RIVA System, collaborating with RVH on this milestone project has reinforced the important role robotic automation plays in the evolution of healthcare. “The signing of this agreement with RVH is another step in the right direction for Canadian Healthcare,” says Szuuts. “We are very excited to be working with RVH. Their commitment to patient and staff safety solidifies their position as leaders in Canadian Healthcare.”
RIVA (Robotic IV Automation System) -a self-contained unit for filling IV syringes and bags- is the first product developed by Winnipeg-based medical device company Intelligent Hospital Systems. To view our latest video of RIVA in operation, click here
Companies in this article
